Healthy adults
Conditions
Interventions
Sponsors
Miura Clinic, Medical Corporation Kanonkai
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Subjects of men and women aged 20 to 64 (2) Subjects with a BMI of 25 or more and less than 30 (3) Subjects who received sufficient explanation about the purpose and content of the test, had the ability to consent, voluntarily volunteered to participate after understanding it well, and agreed to participate in the test in writing.
Exclusion criteria
Exclusion criteria: (1) Subjects with a history of serious diseases such as mental disorders, diabetes, liver diseases, renal diseases, gastrointestinal diseases, cardiac diseases, respiratory diseases, peripheral vascular diseases, or other serious diseases. (2) Subjects who have undergone gastrointestinal surgery. (3) Subjects with abnormal liver and renal function test values. (4) Subjects with diseases currently being treated. (5) Subjects who are allergic to food or drugs. (6) Subjects with symptoms of anemia. (7) Female subjects who wish to become pregnant during the study, or who are pregnant (including those who may be pregnant) or lactating. (8) Subjects who play intense sports or who are on a diet. (9) Subjects with extremely irregular eating habits. (10) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) or quasi-drugs during the study period. (11) Subjects who are continuously treated with pharmaceuticals (including OTC and prescription drugs). (12) Subjects who drink more than 60 g of pure alcohol per day. (13) Subjects who smoke more than 21 cigarettes per day on average. (14) Subjects who are participating in or will participate in other clinical trials at the start of this study. (15) Subjects who are judged by the investigator or subinvestigator to be inappropriate for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Medical interview Physical examination Laboratory test values Adverse event | — |
Countries
Japan
Contacts
Public ContactMakoto Terashima
Oneness Support Co., Ltd. Clinical Trial Division
Outcome results
None listed